Dr. Markman Discusses the Olaparib Phase II Trial

Maurie Markman, MD
Published Online: Wednesday, May 18, 2011
Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America Discusses the Olaparib Phase II Trial
Online CME Activities
Free CME from PER
PARP Inhibitors: Current and Future Options for Breast and Ovarian Cancer
Rapid Summaries and Commentaries: Update from Chicago - Advances in the Treatment of Lung Cancer
Medical Crossfire®: The JAK-STAT Pathway as a Mediator of Onco-Inflammation
2nd Annual Miami Lung Cancer Conference™ Medical Crossfire® Case Discussion
More Reading
$auto_registration$